Lucid Diagnostics Partners With VITALExam, To Enhance Access To Lucid's EsoGuard Esophageal DNA Test For Firefighters At Risk For Esophageal Precancer
Lucid Diagnostics Partners With VITALExam, To Enhance Access To Lucid's EsoGuard Esophageal DNA Test For Firefighters At Risk For Esophageal Precancer
Partnership launched with fully-contracted #CheckYourFoodTube Precancer Testing Event for Tuscaloosa firefighters
與完全合同的#CheckYourFoodTube癌前篩查活動合作，面向塔斯卡盧薩消防員
NEW YORK, Dec. 19, 2024 /PRNewswire/ -- Lucid Diagnostics Inc. (NASDAQ:LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company and subsidiary of PAVmed Inc. (NASDAQ:PAVM), today announced that it has entered into a strategic partnership with VITALExam LLC (VITALExam), a comprehensive medical care provider for first responders founded by Chief Executive Officer Marci Vitale, DNP, FNP-BC, AGACNP-BC, to enhance access to Lucid's EsoGuard Esophageal DNA Test for firefighters at risk for esophageal precancer. Lucid and VITALExam launched the partnership with a fully-contracted #CheckYourFoodTube Precancer Testing Event at Tuscaloosa Fire Rescue in Tuscaloosa, AL, as part of Lucid's expanded direct contracting initiative focused on driving near-term EsoGuard revenue.
紐約，2024年12月19日 /PRNewswire/ -- Lucid Diagnostics Inc. (納斯達克:LUCD) ("Lucid"或"公司"), 一家商業階段的癌症預防醫療診斷公司及PAVmed Inc. (納斯達克:PAVM) 的子公司，今天宣佈已與VITALExam LLC (VITALExam) 建立戰略合作關係，VITALExam是一家爲急救人員提供綜合醫療保健的公司，由首席執行官Marci Vitale, DNP, FNP-BC, AGACNP-BC創立，旨在提高消防員對食道癌前期風險的EsoGuard食道DNA測試的獲取。Lucid和VITALExam以全面合同的#檢查你的食物管癌前期檢測活動爲起點，在阿拉巴馬州塔斯卡盧薩的塔斯卡盧薩消防救援隊啓動了合作，以推動Lucid的擴大直接合同計劃，集中精力推動近期EsoGuard營業收入。
譯文內容由第三人軟體翻譯。